Literature DB >> 17502867

Tumor necrosis factor-alpha and host resistance to the pathogenic fungus, Histoplasma capsulatum.

George S Deepe1.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a multifunctional cytokine that is critically important in host defenses to a number of pathogenic microbes. Among those, this cytokine is necessary for control of infection with the pathogenic fungus, Histoplasma capsulatum. Antagonism of endogenous cytokine is associated with an enhanced susceptibility to histoplasmosis in both mice and humans. The mechanisms by which TNF-alpha modulates the protective immune response will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502867     DOI: 10.1038/sj.jidsymp.5650026

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  5 in total

1.  Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages.

Authors:  Diane O Inglis; Charlotte A Berkes; Davina R Hocking Murray; Anita Sil
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

2.  Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.

Authors:  Allan J Guimarães; Susana Frases; Francisco J Gomez; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 3.  Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Authors:  Jamie Mittal; Maria G Ponce; Inessa Gendlina; Joshua D Nosanchuk
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

4.  Comparison of phylogenetically distinct Histoplasma strains reveals evolutionarily divergent virulence strategies.

Authors:  Victoria E Sepúlveda; Corinne L Williams; William E Goldman
Journal:  MBio       Date:  2014-07-01       Impact factor: 7.867

5.  Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis.

Authors:  Alba Pérez-Cantero; Dolores R Serrano; Patricia Navarro-Rodríguez; Andreas G Schätzlein; Ijeoma F Uchegbu; Juan J Torrado; Javier Capilla
Journal:  Pharmaceutics       Date:  2019-09-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.